drugset / Trial / NCT00163215
Growth Retardation In Children With Special Pathological Conditions Or Disease
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To show an increase in annual growth rate 3 years after Visit 2. Annual growth rate in standard deviation (SD) after 3 years will be compared to growth rate before the start of GH treatment.
Timeline
- Start
- 2005-01
- Primary completion
- 2011-10
- Completion
- 2011-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Somatropin | Protein / enzyme biologic | 0.0033 mg/kg | — |
| Subject | Somatropin | Protein / enzyme biologic | 0.0067 mg/kg | — |